NF-κB2 p100 is a pro-apoptotic protein with anti-oncogenic function

Nature Cell Biology

Volumn 4, Issue 11, 2002, Pages 888-893

  Wang, Yongqing ^a   Cui, Hongjuan ^a   Schroering, Allen ^a   Ding, Jane L ^a   Lane, William S ^b   McGill, Gaél ^c   Fisher, David E ^c   Ding, Han Fei ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b HARVARD UNIVERSITY   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CELL PROTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; NUCLEAR FACTOR KAPPA B2 P100; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ASSAY; CELL DEATH; CELL STRAIN 3T3; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; IRRADIATION; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN ISOLATION; SENSITIZATION; TUMOR CELL; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; APOPTOSIS; CASPASE 8; CASPASES; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CELL-FREE SYSTEM; COLORIMETRY; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOBLOTTING; MASS SPECTROMETRY; MICE; MUTATION; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; NIH 3T3 CELLS; PLASMIDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RETROVIRIDAE; TIME FACTORS; TRANSFECTION; UP-REGULATION;

ANIMALIA;

EID: 0036850143     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb872     Document Type: Article

References (29)

1. Baldwin, A. S. J. Clin. Invest. 107, 241-246 (2001).
2. Rayet, B. & Gelinas, C. Oncogene 18, 6938-6947 (1999).
3. Feinstein, E., Kimchi, A., Wallach, D., Boldin, M. & Varfolomeev, E. Trends Biochem. Sci. 20, 342-344 (1995).
4. Ding, H.-F. et al. J. Biol. Chem. 275, 38905-38911 (2000).
5. Varfolomeev, E. E. et al. Immunity 9, 267-276 (1998).
6. Juo, P., Kuo, C. J., Yuan, J. & Blenis, J. Curr, Biol. 8, 1001-1008 (1998).
7. Vincenz, C. & Dixit, V. M. J. Biol. Chem. 272, 6578-6583 (1997).
8. Zhou, Q. et al. J. Biol. Chem 272, 7797-7800 (1997).
9. Wu, M. et al. EMBO J 15, 4682-4690 (1996).
10. Liu, Z.-G., Hsu, H., Goeddel, D. V. & Karin, M. Cell 87, 565-576 (1996).
11. Beg, A. A. & Baltimore, D. Science 274, 782-784 (1996).
12. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. & Verma, I. M. Science 274, 787-789 (1996).
13. Wang, C. Y., Mayo, M. W. & Baldwin, A. S. Jr Science 274, 784-787 (1996).
14. Kim, K. E. et al. Oncogene 19, 1334-1345 (2000).
15. Solan, N. J., Miyoshi, H., Carmona, E. M., Bren, G. D. & Paya, C. V. J. Biol. Chem. 277, 1405-1418 (2002).
16. Kischkel, F. C. et al. EMBO J. 14, 5579-5588 (1995).
17. Ashkenazi, A. & Dixit, V. M. Science 281, 1305-1308 (1998).
18. Xiao, G., Harhaj, E. W. & Sun, S. C. Mol. Cell 7, 401-419 (2001).
19. Cogswell, P. C., Guttridge, D. C., Funkhouser, W. K. & Baldwin, A. S. Oncogene 19, 1123-1131 (2000).
20. Green, D. R. & Evan, G. Cancer Cell 1, 19-30 (2002).
21. Zhang, J., Chang, C. C., Lombardi, L. & Dalla-Favera, R. Oncogene 9, 1931-1937 (1994).
22. Thakur, S. et al. Oncogene 9, 2335-2344 (1994).
23. Chang, C. C., Zhang, J., Lombardi, L., Neri, A. & Dalla-Favera, R. Mol. Cell. Biol. 15, 5180-5187 (1995).
24. Senftleben, U. et al. Science 293, 1495-1499 (2001).
25. Caamano, J. H. et al. J. Exp. Med. 187, 185-196 (1998).
26. Franzoso, G. et al. J. Exp. Med. 187, 147-159 (1998).
27. Eng, J. K., McCormick, A. L. & Yates, J. R. I. J. Am. Soc. Mass Spectrom. 5, 976-989 (1994).
28. Ory, D., Neugeboren, B. & Mulligan, R. Proc. Natl Acad. Sci. USA 93, 11400-11406 (1996).
29. Finco, T. S., Beg, A. A. & Baldwin, A. S. Jr. Proc. Natl Acad. Sci. USA 91, 11884-11888 (1994).